Upcoming MDPI Conferences (2)
1–15 December 2022 2nd International Electronic Conference on Biomolecules: Biomacromolecules and the Modern World Challenges (IECBM2022)
It is with great pleasure that we announce the 2nd International Electronic Conference on Biomolecules: Biomacromolecules and the Modern World Challenges (IECBM2022). The conference is organized by the MDPI open-access journal Biomolecules (Impact Factor 6.064), and will be held online from 1 to 15 December 2022.
This conference will provide leading scientists working in the field with an online platform in which to share their latest research and engage in exciting discussions. The main topics and sessions of the conference are:
Biomacromolecules: Nucleic Acids;
This online event will bring together researchers from all over the world without travel concerns or other related expenditures. Participation in and “attendance” to the IECBM2022 are free of charge.
The conference invites submissions for abstracts that will be reviewed by the conference committee. The authors of the accepted contributions will be invited to submit a conference paper along with a slide or poster presentation of their work. All participants will have the opportunity to examine, explore, and critically engage with research findings published in Sciforum during the conference.
After the conference, all accepted papers will be published in the proceedings of this e-conference within a dedicated issue of the MDPI journal Proceedings. In addition, all participants will be encouraged to submit a full paper to one dedicated Special Issue in Biomolecules with a 20% discount on the article processing charges (APC).
We hope that you will join this e-conference to exchange ideas, start fruitful collaborations, and make this first edition the first of many successes.
Prof. Dr. Vladimir N. Uversky, PhD, DSc, FRSB, FRSC
16–30 March 2023 3rd International Electronic Conference on Cancers: New Targets for Cancer Therapies (IECC 2023)
We are pleased to announce the 3rd International Electronic Conference on Cancers: New Targets for Cancer Therapies (IECC 2023). The conference is organized by the MDPI open-access journal Cancers ( IF 6.575) and will be held online from 16–30 March 2023.
Abstract Submission Deadline: 5th January 2023
Notification of Acceptance Deadline: 31st January 2023
Full Paper Submission Deadline: 13th February 2023
Conference Open: 16–30 March 2023
Opportunities for new therapeutic targets have expanded tremendously. In recent years, cancer genomics has expanded our view of cancer vulnerabilities, new technologies have changed the paradigm of what can be successfully targeted, and new immunotherapy targets continue to emerge at a rapid pace. This conference aims to promote and advance the coordinated progress in oncology research to foster the development of innovative therapeutic strategies. It will bring together experts in basic, translational, and clinical research to discuss the current research and opportunities as well as the obstacles that lie ahead in the field.
The focus of this conference is the translation of recent discoveries into new therapeutic targets for cancer therapies. Topics of interest include but are not limited to the following:
- Translational cancer genomics and epigenomics;
- Emerging immunotherapy targets;
- Overcoming therapeutic hurdles in resistance and undruggable proteins.
There will be five specific sessions:
Session 1: Genome-Wide Approaches for Target Identification;
Session 2: Targeting Metastasis;
Session 3: Novel Immunotherapy Targets;
Session 4: Novel Approaches for ‘Undruggable’ Targets;
Session 5: Overcoming Therapeutic Resistance.
Participants will have the opportunity to examine, explore, and critically engage with issues and advances in these areas. We hope to facilitate discussions and exchange within the community.
This event will be a solely online proceeding, which allows for participation from around the world with no concerns regarding travel and related expenditures. This type of conference is particularly appropriate and useful, as cancer-related research is progressing rapidly. An electronic conference provides a platform for rapid and direct exchanges about the latest research findings and novel ideas. Attendance and participation in this online conference is completely free.
The accepted conference proceedings papers and presentations will be available online for discussion on 16–30 March 2023 and will be published in the journal Medical Sciences Forum. All participants are encouraged to submit an extended full manuscript to the Cancers conference Special Issue "IECC2023: New Targets for Cancer Therapies" with a 20% discount on the APC. Cancers (ISSN 2072-6694; IF 6.575) is a peer-reviewed and open access journal of oncology that is published semimonthly online by MDPI.
We hope that the community will share our enthusiasm and help to make this conference a success.
Dr. Carlos S. Moreno
The Chair of the 3rd International Electronic Conference on Cancers: New Targets for Cancer Therapies
Cancers announces selected third-party conferences. In case you would like to announce your own event on the Cancers website, please fill out the following form to apply for the announcement of a conference or other academic event (seminar, workshop).
Upcoming Partner Conferences (3)
1–3 December 2022 The 8th Symposium on Advances in Cancer Immunology and Immunotherapy (SACII)
The 8th Symposium on Advances in Cancer Immunology and Immunotherapy (SACII) (http://www.sacii-greece.org), which will take place on 1–3 December 2022 in Athens, Greece, is focused on the most recent advances in immuno-oncology. The 8th Symposium on “Advances in Cancer Immunology and Immunotherapy” is an intensive, three-day interactive meeting during which invited speakers will address the current and accumulated knowledge of basic immuno-biology and translational cancer research, as well as therapeutic developments in the field of cancer immunotherapy according to the most recent clinical trials.
The scientific objectives of this symposium are focused on the: (a) predictive and prognostic biomarkers for immunotherapy, (b) mechanisms of action of different immunotherapeutic treatments, (c) efficacy and safety data of cancer immunotherapy regimens, and (d) strategies for immunomodulation, counteracting resistance and mitigating adverse events. Additionally, this year’s symposium will feature world-renowned oncologists and researchers who will provide their insights into the abovementioned topics in an effort to better understand tumor evolution and design improved treatment strategies.
The 8th Symposium on “Advances in Cancer Immunology and Immunotherapy” welcomes the participation of scientists, clinicians, students, and healthcare professionals interested in the field of Cancer Immunology and Immunotherapy
20–23 April 2023 Global Meet on Cancer Research and Clinical Oncology (GMCRCO2023)
We are gathering a world-class panel of expert speakers to address you from both international and regional communities. This congress will provide you with a platform to share experiences and discuss breakthroughs in various specialist fields and a necessary criterion to successfully assess and expand your own practices. We have included keynote lectures, round table discussions, video sessions and the latest research in technology, covering a wide array of topics to introduce you to the latest technologies and techniques in the field of Prime meetings 2023.
Prime meetings 2023 will also have several workshops, and from the wide array of presentations submitted to us by the research committee, the scientific committee will choose the best ones to be recognised and awarded. We have kept the registration fee at an affordable rate to encourage the participation of young, upcoming practitioners and scientists. The congress venue is conveniently located in the centre of the city, close to the airport, metro stations, and shopping destinations. We have great pride in welcoming you to OSAKA. We are confident that this Congress will exceed your expectations, offering an exciting scientific event as well as an enjoyable social and cultural experience.
26–29 April 2023 The 12th International Charité Mayo Conference: Global Perspectives and Future Directions in Women’s Cancer
We are happy to invite you to the 12th International Charité Mayo Conference on “Global Perspectives and Future Directions in Women’s Cancer”, which will be held from April 26–29, 2023, in Berlin, Germany.
International luminaries will depict and discuss the newest developments in gynecologic oncology and breast cancer.
The International Charité Mayo Conference will feature the hottest topics in gynecological oncology—including 12 hours of live surgeries, debates, intensive workshops, and international panel discussions.
We would be happy to welcome you to the German capital.